According to Cognitive Market Research, The Global Asthma and COPD Drug market size is USD 34512.2 million in 2023 and will expand at a compound annual growth rate (CAGR) of 5% from 2023 to 2030.
North America Asthma and COPD Drugsheld the major market of more than 40% of the global revenue with a market size of USD 13804.88 million in 2023 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2023 to 2030.
Europe Asthma and COPD Drugsaccounted for a share of over 30% of the global market size of USD 10353.6 million in 2023.
Asia Pacific Asthma and COPD Drugheld the market of more than 23% of the global revenue with a market size of USD 7937.81 million in 2023 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2023 to 2030,
Latin America's Asthma and COPD Drugmarket of more than 5% of the global revenue with a market size of USD 1725.61 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2023 to 2030.
Middle East and Africa Asthma and COPD Drugsheld the major market of more than 2% of the global revenue with a market size of USD 690.24 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2023 to 2030.
Technological developments in new medications by key market players.
Demand for monoclonal antibodies remains higher in the asthma and COPD drug market.
The asthma patients category held the highest asthma and COPD drug market revenue share in 2023.
